The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Archivum Immunologiae et Therapiae Experimentalis

• Publication date

  2013-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00005-013-0222-5PMID 23456207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.

  2012cited by this paper
• Glucose Metabolism Disorders and the Risk of Cancer

  2011cited by this paper
• Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

  2011cited by this paper
• The function of natural killer cells: education, reminders and some good memories.

  2011cited by this paper
• Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

  2011cited by this paper
• A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity

  2011cited by this paper
• IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production

  2011cited by this paper
• Risk of cancer in a large cohort of U.S. veterans with diabetes

  2011cited by this paper
• Immunotherapy targeting colon cancer stem cells.

  2011cited by this paper
• Metformin: A Therapeutic Opportunity in Breast Cancer

  2010cited by this paper
• Diabetes and risk of incident colorectal cancer in a prospective cohort of women

  2010cited by this paper
• [Colorectal cancer screening].

  2010cited by this paper
• Risk of Cancer Following Hospitalization for Type 2 Diabetes

  2010cited by this paper
• NCCN clinical practice guidelines in oncology. Colorectal cancer screening.

  2010cited by this paper
• The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

  2010cited by this paper
• Effect of screening colonoscopy on colorectal cancer incidence and mortality.

  2009cited by this paper
• Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies

  2009influential reference
• American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

  2009cited by this paper
• NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

  2009cited by this paper
• The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• Obesity and diabetes epidemics: cancer repercussions.

  2008cited by this paper
• Biology of Natural Killer Cells

  2008cited by this paper
• Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.

  2008cited by this paper
• Type 2 diabetes mellitus as risk factor for colorectal cancer

  2008cited by this paper
• Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

  2007cited by this paper
• Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

  2007cited by this paper
• Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.

  2006cited by this paper
• A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women

  2005cited by this paper
• Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

  2005cited by this paper
• Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.

  2005cited by this paper
• A prospective study of plasma C-peptide and colorectal cancer risk in men.

  2004influential reference
• Unravelling natural killer cell function: triggering and inhibitory human NK receptors

  2004cited by this paper
• Statistical Methods in Medical Research, 4th edn

  2003cited by this paper
• Arch.Immunol.Ther.Exp.

  2000cited by this paper
• Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

  2000cited by this paper
• Determination of natural killer cell function by flow cytometry

  1996cited by this paper
• A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity.

  1995cited by this paper
• Similar alterations of lymphocyte subpopulations in type I and type II diabetes.

  1993cited by this paper
• Developmental and maturational changes in human blood lymphocyte subpopulations.

  1992cited by this paper
• Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.

  1992cited by this paper
• Biology and clinical relevance of human natural killer cells.

  1990cited by this paper
• The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures

  1990cited by this paper
• Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.

  1989cited by this paper
• Effect of various cytokines and growth factors on the interleukin-2-dependent in vitro differentiation of natural killer cells from bone marrow.

  1989cited by this paper
• Characterization of functional surface structures on human natural killer cells.

  1988cited by this paper
• Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.

  1986cited by this paper
• Immunobiology of Natural Killer Cells

  1986cited by this paper
• Natural killer cell activity following T‐cell depleted allogeneic bone marrow transplantation

  1986cited by this paper
• Natural killer cells: definition of a cell type rather than a function.

  1986cited by this paper
• Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

  1981cited by this paper
• Natural killer cells: their roles in defenses against disease.

  1981cited by this paper
• Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.

  1980cited by this paper
• A new immunodeficiency disorder in humans involving NK cells

  1980cited by this paper
• The functional dissection of human peripheral null cells with respect to antibody‐dependent cellular cytotoxicity and natural killing

  1979cited by this paper
• Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity

  1975cited by this paper
• Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells

  1975cited by this paper
• Lymphocyte cytotoxicity reactions to leukemia‐associated antigens in identical twins

  1972cited by this paper

• Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes

  2025cites this paper
• Diabetes can impact cellular immunity in solid tumors.

  2025cites this paper
• Immune cell dysfunction: A critical player in development of diabetes complications.

  2025cites this paper
• Circular RNA: From non-coding regulators to functional protein encoders

  2025cites this paper
• Integrated Bioinformatics Analysis Revealed Immune Checkpoint Genes Relevant to Type 2 Diabetes

  2024cites this paper
• Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy

  2024cites this paper
• Exploring the Molecular Mechanism of Comorbidity of Type 2 Diabetes Mellitus and Colorectal Cancer: Insights from Bulk Omics and Single-Cell Sequencing Validation

  2024cites this paper
• The molecular mechanism of "Dahuang-Shengjiang-Banxia decoction" in the treatment of diabetic kidney disease was verified based on network pharmacology and molecular docking

  2024cites this paper
• Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression.

  2023cites this paper
• Glucose metabolism disorder: a potential accomplice of SARS-CoV-2

  2023cites this paper
• Contribution of natural killer cells in innate immunity against colorectal cancer

  2023influential citation
• Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients

  2022cites this paper
• When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors

  2022cites this paper
• Activation of Peripheral Blood Mononuclear Cells and Leptin Secretion: New Potential Role of Interleukin-2 and High Mobility Group Box (HMGB)1

  2021cites this paper
• Targeting metabolism to potentiate NK cell-based therapies

  2021cites this paper
• Immunometabolic bases of type 2 diabetes in the severity of COVID-19

  2021cites this paper
• Diabetes Induces a Transcriptional Signature in Bone Marrow–Derived CD34+ Hematopoietic Stem Cells Predictive of Their Progeny Dysfunction

  2021cites this paper
• The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy

  2021cites this paper
• NK cell-mediated immunotherapy: The exquisite role of PGC-1a in metabolic reprogramming

  2021cites this paper
• Progress in understanding of relationship between diabetes and colorectal cancer

  2021cites this paper
• Natural killer cell levels in adults living with type 2 diabetes: a systematic review and meta-analysis of clinical studies

  2020influential citation
• Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy

  2020cites this paper
• Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.

  2020cites this paper
• The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System

  2020cites this paper
• Conditional Deletion of PGC-1α Results in Energetic and Functional Defects in NK Cells

  2020cites this paper
• Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes

  2019cites this paper
• Natural Killer Cells and Health Status: Age, CMV Infection, and Obesity

  2019cites this paper
• Immunostimulatory effect of kumquat (Fortunella crassifolia) and its constituents, β-cryptoxanthin and R-limonene.

  2019cites this paper
• Glycation interferes with natural killer cell function.

  2019cites this paper
• Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus

  2018cites this paper
• The Role of Gamma Delta T Cells in Adipose Tissue Biology

  2018cites this paper
• Appendix: The Clinician’s Guide to Examination of the Diabetic Foot

  2018cites this paper
• Functional status of immune cells in patients with long‐lasting type 2 diabetes mellitus

  2018cites this paper
• Diabetes Mellitus at the Time for Diagnosis : Studies on Prognostic Factors

  2017cites this paper
• IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis.

  2017cites this paper
• A PROSPECTIVE STUDY OF PREDICTORS OF MORTALITY IN ACUTE RESPIRATORY FAILURE IN H1N1 INFLUENZA

  2017cites this paper
• Expression of Natural Cytotoxicity Receptors on and Intracellular Cytokine Production by NK Cells in Women with Gestational Diabetes Mellitus

  2016cites this paper
• Prognostic value of glycated hemoglobin in colorectal cancer

  2016cites this paper
• NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer

  2016cites this paper
• Diagnostic Value of Serum Ghrelin Levels in Diabetic Men with Benign Prostate Hypertrophy

  2015cites this paper
• Evaluation of Interferon-Gamma in Patients with Type 2 Diabetes and Colorectal Cancer

  2015cites this paper